Hos patienter, der vejer over 100 kg (se pkt. 5. 1) er dosis 90 mg indgivet subkutant i uge 0, efterfulgt af en dosis på 90 mg i uge 4 og dernæst hver 12. uge.
Patients with body weight > 100 kg For patients with a body weight > 100 kg the dose is 90 mg administered subcutaneously at week 0, followed by a 90 mg dose at week 4, then every 12 weeks thereafter (see section 5.1).